AEON Biopharma gets FDA Type 2b feedback on ABP-450 biosimilar path, files CMAP INDNov 16Quarterly updateAEON Biopharma, Inc.
AbbVie registers Phase 1 PK study of trosunilimab given IV and SC in healthy adultsNov 13Weekly roundup, 8 itemsABBV-295ABBV-722
Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Sanofi's Phase 3 vYF yellow fever vaccine trial in children active, not recruitingNov 6Weekly roundup, 4 itemsbelumosudilcetirizine hydrochloride and pseudoephedrine hydrochloride
Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
IDEAYA completes darovasertib NDA, halts Phase 3 OptimUM-010 for enrollment issuesNov 3Quarterly updateAlector, Inc.Allogene Therapeutics
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
UIC registers Phase 1 trial of Pfizer's elranatamab in plasmablastic lymphomaOct 30Weekly roundup, 11 itemsAstellas Pharmaatirmociclib
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Tiziana doses last patient in Phase 2 Alzheimer's trial of intranasal foralumabOct 16Clinical readoutforalumabTiziana Life Sciences LTD
Recursion prices $200M offering, reports Sanofi milestone and TUPELO, DAHLIA dataOct 15Quarterly updateAlector, Inc.REC-1245Updated
FDA approves labeling supplement for Jazz's Zepzelca (lurbinectedin)Sep 30Regulatory decisionJazz Pharmaceuticalslurbinectedin
Jazz-linked lurbinectedin GI trial posts results; new JZP269 Phase 1 study registeredSep 11Weekly roundup, 2 itemsJazz PharmaceuticalsJZP269
Trinity Biotech's Trinovium unit partners with Echelon on AI data center coolingAug 17PartnershipTrinity Biotech Plc
Acumen reports Q2 2026 results, reaffirms ALTITUDE-AD readout for late 2026Aug 12Quarterly updateAcumen Pharmaceuticals
SIGA reports $37 million in TPOXX sales for second quarter of 2026Aug 6Quarterly updateSIGA Technologiestecovirimat
Voyager reports Q2 2026 results, sets Q4 milestones for two Alzheimer's programsAug 6Quarterly updateVoyager TherapeuticsVY1706
Generate Biomedicines reports Q2 2026 results, advances asthma and oncology pipelineAug 6Quarterly updateGenerate Biomedicines
QuidelOrtho cuts full-year 2026 guidance on China pricing pressureAug 6Quarterly updateQuidelOrtho Corp
IDEXX reports second quarter revenue growth of 10%, raises full year outlookAug 4Quarterly updateIdexx Laboratories Inc /De
Tonix says FDA aligns on Phase 2 design for Lyme antibody TNX-4800Aug 3Regulatory milestoneTonix Pharmaceuticals, Inc.
Jazz Pharmaceuticals reports 2Q26 results, raises 2026 revenue guidanceAug 3Quarterly updateJazz Pharmaceuticalszanidatamab-hrii